MODIFIED AMINOGLYCOSIDE COMPOUNDS AND USES THEREOF IN DISABLING BACTERIAL RIBOSOME

Timor Baasov; Boris Smolkin; Alina Khononov; Michal Shavit Kishkober; Valery Belakhov

MODIFIED AMINOGLYCOSIDE COMPOUNDS AND USES THEREOF IN DISABLING BACTERIAL RIBOSOME

Timor Baasov (Inventor), Boris Smolkin (Inventor), Alina Khononov (Inventor), Michal Shavit Kishkober (Inventor), Valery Belakhov (Inventor)

Research output: Patent

Abstract

Modified aminoglycoside compounds represented by Formula I as defined and described in the specification are provided. The modified aminoglycosides feature a diamine-containing functional moiety at one or more of positions 3′, 4′ and 6′. Uses of the modified aminoglycosides as antimicrobial (e.g., antibacterial) agents, and in treating medical conditions associated with microorganisms, are also provided.

Original language	American English
Patent number	US2021275557
IPC	A61K 31/ 7036 A I
Priority date	20/05/21
State	Published - 9 Sep 2021

Cite this

@misc{6bc3c22b5f0f44f0b6a4acb0d63f5fa8,

title = "MODIFIED AMINOGLYCOSIDE COMPOUNDS AND USES THEREOF IN DISABLING BACTERIAL RIBOSOME",

abstract = "Modified aminoglycoside compounds represented by Formula I as defined and described in the specification are provided. The modified aminoglycosides feature a diamine-containing functional moiety at one or more of positions 3′, 4′ and 6′. Uses of the modified aminoglycosides as antimicrobial (e.g., antibacterial) agents, and in treating medical conditions associated with microorganisms, are also provided.",

author = "Timor Baasov and Boris Smolkin and Alina Khononov and {Shavit Kishkober}, Michal and Valery Belakhov",

year = "2021",

month = sep,

day = "9",

language = "American English",

type = "Patent",

note = "US2021275557; A61K 31/ 7036 A I",

}

TY - PAT

T1 - MODIFIED AMINOGLYCOSIDE COMPOUNDS AND USES THEREOF IN DISABLING BACTERIAL RIBOSOME

AU - Baasov, Timor

AU - Smolkin, Boris

AU - Khononov, Alina

AU - Shavit Kishkober, Michal

AU - Belakhov, Valery

PY - 2021/9/9

Y1 - 2021/9/9

N2 - Modified aminoglycoside compounds represented by Formula I as defined and described in the specification are provided. The modified aminoglycosides feature a diamine-containing functional moiety at one or more of positions 3′, 4′ and 6′. Uses of the modified aminoglycosides as antimicrobial (e.g., antibacterial) agents, and in treating medical conditions associated with microorganisms, are also provided.

AB - Modified aminoglycoside compounds represented by Formula I as defined and described in the specification are provided. The modified aminoglycosides feature a diamine-containing functional moiety at one or more of positions 3′, 4′ and 6′. Uses of the modified aminoglycosides as antimicrobial (e.g., antibacterial) agents, and in treating medical conditions associated with microorganisms, are also provided.

M3 - Patent

M1 - US2021275557

ER -

MODIFIED AMINOGLYCOSIDE COMPOUNDS AND USES THEREOF IN DISABLING BACTERIAL RIBOSOME

Abstract

Fingerprint

Cite this